Tove Larsson
Founding General Partner
86%Norrsken VC
Check: Norrsken VC currently states €1M–€10M early-stage and growth tickets. This is the firm's range, not Tove's personal promise. Confirm initial ticket, follow-on reserves, ownership and stage with the team.
Tove backs ambitious European technology companies whose commercial growth directly improves outcomes for people or planet. Her Bain private-equity background and early impact roles add rigorous market and diligence discipline. Current health-AI work highlights companies that combine deep sector expertise, proprietary data and measurable time or cost improvements in critical systems such as clinical trials.
Early StageSeedSeries A